一种跨诊断性睡眠干预,用于睡眠问题和并发性精神健康障碍的门诊患者,来自丹麦质量保证项目的数据
Henny Dyrberg1, Sanne Toft Kristiansen1,2, Maria Speed1,2
1Department of Affective Disorders, Aarhus University Hospital Psychiatry, Aarhus, Denmark.
Nordic journal of psychiatry
|October 10, 2025
概括
这项研究表明,结合CBT-I和慢性治疗的跨诊断性睡眠干预显著改善了睡眠质量,并减少了精神病患者的失眠严重程度. 这种干预对患有双相情感障碍,单相情感抑郁症和多动症的人特别有效.
科学领域:
- 精神病学是一个精神病学.
- 睡眠医学 睡眠医学
- 时间生物学 时间生物学
背景情况:
- 失眠在精神病患者中很普遍,通常与其他睡眠障碍 (如延迟睡眠阶段) 一起发生.
- 失眠的认知行为疗法 (CBT-I) 是主要的治疗方法,但复杂的睡眠问题需要更广泛的方法.
- 丹麦的跨诊断睡眠和昼夜干预在2019年被开发出来,将CBT-I与慢性治疗结合起来.
研究的目的:
- 评估跨诊断睡眠和昼夜干预对睡眠质量和失眠严重性的有效性.
- 确定与治疗结果积极相关的患者诊断特征.
- 在临床精神病学环境中评估干预的有效性.
主要方法:
- 实施了一个跨诊断的睡眠和昼夜干预,包括六个单独的会议.
- 数据包括主观睡眠质量和失眠严重程度,采集于干预前后.
- 人口统计和诊断信息被收集用于分析.
主要成果:
- 总共有248名患者完成了干预.
- 观察到失眠严重程度的统计显著减少,特别是在双相情感障碍和单极抑郁症患者中.
- 睡眠质量有显著的改善,在患有注意力缺陷多动症患者中观察到的最实质性的变化.
结论:
- 跨诊断睡眠和昼夜干预有效地改善了慢性睡眠问题患者的睡眠.
- 这项由跨学科团队进行的干预包括CBT-I,慢性治疗和同行支持.
- 这项质量保证研究强调了该干预措施对不同精神病患者群体的临床实用性.
相关概念视频
Blind Procedures
10.8K
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
10.8K
Management of Insomnia
785
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
785
Sedatives and Hypnotics Drugs: Miscellaneous Agents
981
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
981
Insomnia
620
Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
Multiple factors contribute...
620
REM Sleep Behavior Disorder
2.9K
REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
RBD is significantly associated with...
2.9K


